Neoadjuvant Cytoreductive Treatment With BRAF / MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial
- Stéphanie A. Blankenstein
- , Maartje W. Rohaan
- , Willem Martin C. Klop
- , Bernies Van Der Hiel
- , Bart A. Van De Wiel
- , Max J. Lahaye
- , Sandra Adriaansz
- , Karolina Sikorska
- , Harm Van Tinteren
- , Aysegül Sari
- , Lindsay G. Grijpink-Ongering
- , Winan J. Van Houdt
- , Michel W.J.M. Wouters
- , Christian U. Blank
- , Sofie Wilgenhof
- , Johannes V. Van Thienen
- , Alexander C.J. Van Akkooi
- , John B.A.G. Haanen
Research output: Contribution to journal › Article › peer-review
38
Citations
(Scopus)